rocuronio kabi
fresenius kabi italia s.r.l. - rocuronio bromuro - rocuronio bromuro
rocuronio sandoz
sandoz s.p.a. - rocuronio bromuro - rocuronio bromuro
rocuronio b.braun
b. braun melsungen ag - rocuronio bromuro - rocuronio bromuro
rocuronio pfizer
pfizer italia s.r.l. - rocuronio bromuro - rocuronio bromuro
rocuronio hikma
hikma farmaceutica (portugal) s.a. - rocuronio bromuro - rocuronio bromuro
xsysto
karo healthcare ab - pivmecillinam - pivmecillinam
infectofos
infectopharm arzneimittel und consilium gmbh - fosfomicina - fosfomicina
extraflex
baxter s.p.a. - soluzioni isotoniche - soluzioni isotoniche
bleomicina accord
accord healthcare, s.l.u. - bleomicina - bleomicina
zinforo
pfizer ireland pharmaceuticals - ceftaroline fosamil - community-acquired infections; skin diseases, infectious; pneumonia - antibatterici per uso sistemico, - zinforo is indicated for the treatment of the following infections in neonates, infants, children, adolescents and adults: , complicated skin and soft tissue infections (cssti), community-acquired pneumonia (cap) , consideration should be given to official guidance on the appropriate use of antibacterial agents.